Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,755 | -55,356 | -55,489 | -37,966 | 17,859 |
| Depreciation Amortization | 3,139 | 797 | 550 | 512 | 418 |
| Accounts receivable | -285 | 7 | 1,882 | 49,032 | -20,885 |
| Accounts payable and accrued liabilities | 2,610 | 2,982 | 188 | -434 | 729 |
| Other Working Capital | 16,371 | -52,956 | -26,415 | 44,128 | -22,290 |
| Other Operating Activity | 34,299 | 23,383 | 9,161 | -38,836 | 29,047 |
| Operating Cash Flow | $-75,621 | $-81,143 | $-70,123 | $16,436 | $4,878 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,020 | -15,409 | -790 | -838 | -723 |
| Purchase Of Investment | -307,449 | -445,671 | -211,973 | -192,480 | -133,845 |
| Sale Of Investment | 418,688 | 178,720 | 200,237 | 140,250 | 150,170 |
| Investing Cash Flow | $92,219 | $-282,360 | $-12,526 | $-53,068 | $15,602 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,358 | N/A | 14,911 | 4,676 |
| Debt Repayment | -1,049 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 7,405 | 355,972 | 96,133 | 10,467 | 3,269 |
| Other Financing Activity | -5,273 | -3,709 | -1,313 | -678 | -429 |
| Financing Cash Flow | $1,083 | $356,621 | $94,820 | $24,700 | $7,516 |
| Beginning Cash Position | 33,377 | 40,259 | 28,088 | 40,020 | 12,024 |
| End Cash Position | 51,058 | 33,377 | 40,259 | 28,088 | 40,020 |
| Net Cash Flow | $17,681 | $-6,882 | $12,171 | $-11,932 | $27,996 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,621 | -81,143 | -70,123 | 16,436 | 4,878 |
| Capital Expenditure | -19,020 | -15,409 | -790 | -838 | -723 |
| Free Cash Flow | -94,641 | -96,552 | -70,913 | 15,598 | 4,155 |